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Maitotoxin (MTX) induced exocytotic secretion of ATP from PCI2 rat pheochromocytoma cells. The threshold for stim- 
ulation of secretion was at concentrations of about 2 ng/ml of MTX. Maximal release occurred at 40 ng/ml. MTX-in- 
duced ATP release required the presence ofcalcium in the extracellular medium and could be inhibited by nifedipine, 
a specific blocker of voltage-dependent calcium channels. In addition to the effects on ATP secretion from PCI2 cells, 
MTX stimulated the breakdown of phosphoinositides, as measured by the accumulation f rH]inositol phosphates. Max- 
imal stimulation of phosphoinositide breakdown was reached at only 0.5-1.0 ng/ml MTX. MTX at concentrations re-
quired to evoke ATP release (> 2 ng/ml) had lesser or no effect on phosphoinositide br akdown. Although stimulation 
of phosphoinositide br akdown by MTX was dependent on extracellular calcium, itwas insensitive tothe calcium channel 
blockers nifedipine, D-600 and cobalt ions. The different concentration range required to elicit these responses and the 
varying sensitivity ocalcium channel blockers indicate that MTX-evoked secretion and MTX-stimulated phosphoinosit- 
ide breakdown are independent phenomena in PC I2 cells. 
ATP secretion; Phosphoinositide br akdown; Maitotoxin; (PC 12 cell) 
1. INTRODUCTION 
Maitotoxin (MTX) is a potent toxin present in 
the dinoflagellate Gambierdiscus toxicus [1]. MTX 
increases resting tension in cardiac muscle [2], 
causes contraction of smooth muscle [3], induces 
insulin release [4] and stimulates quantal  release of 
neurotransmitters [1,5,6]. These effects of MTX 
require the presence of calcium in the extracellular 
medium. Furthermore, MTX- induced release of 
neurotransmitters is inhibited by dihydropyridine 
calcium channel blockers [1,6]. Thus, it has been 
proposed [1] that MTX is a direct calcium channel 
activator. 
Here, we demonstrate the inhibitory effects of 
the dihydropyridine nifedipine on MTX-evoked 
release of ATP  from PC12 cells. However, MTX-  
induced calcium-dependent phosphoinosit ide 
breakdown in the same cells is not affected by 
nifedipine or other calcium channel blockers. 
Moreover, lower concentrations of MTX are re- 
quired to stimulate phosphoinosit ide breakdown 
than those required to evoke ATP  release from 
PC12 cells. 
2. MATERIALS  AND METHODS 
2.1. Materials 
MTX was isolated from G. toxicus as described [1]. Culture 
media and sera were from Gibco (Grand Island, NY). 
Nifedipine and tetrodotoxin were from Sigma (St. Louis, MO), 
[3H]inositol (12-17 Ci/mmol) from New England Nuclear 
(Boston, MA), methoxyverapamil (D600) from Knoll (Lud- 
wigshafen am Rhein, FRG) and luciferin-luciferase mixture 
from Analytical Luminescence Laboratory (San Diego, CA). 
Correspondence address: F. Gusovsky, Laboratory of 
Bioorganic Chemistry, NIDDK, National Institutes of Health, 
Bethesda, MD 20892, USA 
2.2. Cell culture 
PCI2 cells, derived from a pheochromoCytoma tumor of the 
rat adrenal medulla, were kindly provided by Dr G. Guroff 
(NIH, Bethesda, MD). PCI2 cells were grown in Dulbecco's 
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modified Eagle's medium with 6% fetal calf serum, 6% horse 
serum and penicillin (100 U/ml) and streptomycin (100/zg/ml). 
Cells were grown at 37°C in an atmosphere enriched in CO2. 
2.3. Phosphoinositide breakdown 
The day before the experiment the cells were transferred from 
150-cm 2culture flasks and subcultured in 6-well dishes (35 mm 
diameter wells) and incubated with 10/~Ci/ml [3H]inositol 
(14-17 Ci/mmol) for 14-16 h. The procedure was essentially 
as described by Chuang [7] for NCB-20 cells. [3H]Inositol- 
labelled cells were washed twice with Hepes buffer containing 
118 mM NaCl, 4.7 mM KCI, 2 mM CaCI2, 1.2 mM MgSO4, 
1.2 mM KH2PO4, 0.5 mM EDTA, l0 mM glucose and 20 mM 
Hepes; pH 7.4. The cells were then incubated in Hepes buffer 
containing 60 mM LiCl (osmolarity maintained by reducing 
NaCl to 58 mM) for 20 min. Agents were then added and in- 
cubations continued for 30 min at 37°C. Cells were scraped 
from the plates and transferred to 1.5-ml microfuge tubes. 
After centrifugation (1 ~nin) the supernatant was discarded and 
1 ml 6% trichloroacetic a id was added. The tubes were vortex- 
mixed, centrifuged for 15 min and the supernatant was applied 
to anion-exchange columns (Bio Rad AG IX8, 100-200 mesh 
formate form). Separation and elution of inositol phosphates 
were performed according to Berridge t al. [8]. Results are ex- 
pressed as cpm in [3H]inositol phosphate per 10000 cpm in 
lipids, or as percent of control. 
2.4. Release of  ATP  in PCI2 cells 
ATP release from PCI2 cells was measured as described 
elsewhere for bovine chromaffin cells [9]. Briefly, the lumines- 
cent oxidation of luciferin catalyzed by luciferase was used to 
detect ATP secreted by the cells. The contents of one vial of 
luciferin-luciferase mixture was dissolved in 5 ml Krebs Hepes 
solution (in mM: 135 NaCl, 10 NaHCO3, 10 NaHepes, 5KCI, 
2.6 CaC12, 2 MgCl2, 10 glucose; pH 7.4). The assay was carried 
out by mixing 140/~1 Krebs Hepes solution containing freely 
suspended PC12 cells, plus 50/~1 luciferin-luciferase solution. 
Agents were added in 10-20/zl in Krebs Hepes solution. Light 
was measured with a custom-made light detector [9]. 
3. RESULTS 
MTX (2-20 ng/ml) elicited ATP release from 
freely suspended PC12 cells (fig.l). Concentra- 
tions of MTX below 2 ng/ml did not induce 
measurable secretion of ATP in PC12 cells. MTX- 
induced secretion of ATP from PC12 cells was ap- 
parent 2 s after the addition of MTX and reached 
a maximum level after 30-60 s. Release of ATP 
was observed with concentrations of MTX of 
2 ng/ml, while the maximal response was reached 
at about 40 ng/ml. MTX-induced release of ATP 
was markedly inhibited in the absence of  ex- 
tracellular calcium (not shown) and in the presence 
of 10/~M nifedipine (fig.2). 
MTX induced the formation of [3H]inositol 
phosphates in PCI2 cells in the presence of  LiCI, 
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Fig.l. MTX-evoked ATP release from freely suspended PC12 
cells. Chart records of the photomultiplier output representing 
the time integral of the ATP released in the reaction chamber. 
About 2.5 x 105 cells were added to the reaction mixture. 
Arrows indicate the addition of 20/~l Krebs solution containing 
increasing amounts of MTX (final concentration in 
parentheses). At the end of each experiment, the amplifier gain 
was attenuated by a factor of 100 and 10/~1 of a 1% Triton 
solution was added as indicated by the arrows. The signal gave 
the total ATP remaining in the cells. 
a measure of phosphoinositide breakdown (fig.3). 
A maximal response was observed at 
0.5-1.0 ng/ml MTX. Higher concentrations of 
MTX had smaller or no effect on phosphoinositide 
breakdown (fig.3). The effects of MTX on 
phosphoinositide breakdown were abolished when 
calcium was omitted from the incubation buffer, 
but were unaffected in sodium-free medium (table 
1). Blockers of calcium channels, such as 
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Fig.2. Inhibition of MTX-evoked ATP release by nifedipine. 
Recordings of release of ATP evoked by MTX (4 ng/ml) in the 
absence (left) and presence (right) of 1/~M nifedipine. See 
details for calibration in legend to fig. 1. 
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Fig.3. Dose-dependent stimulation of phosphoinositide 
breakdown by MTX. PCI2 cells labelled with [3H]inositol were 
preincubated with Hepes buffer with LiC1 for 20 min. MTX 
was added and incubations were carried out for 30 rain at 37°C. 
[3H]Inositol phosphates were separated and analyzed as 
described in section 2. (o) [3H]Inositol monophosphate, (n) 
[3H]inositol bisphosphate, (A) [3H]inositol trisphosphate. 
Results are from a representative experiment repeated three 
times. 
nifedipine and D600, or cobalt ions, did not inhibit 
MTX-elicited phosphoinositide breakdown (table 
1, and not shown). 
Table 1 
Effects of nifedipine, calcium-free and sodium-free media on 
maitotoxin-stimulated phosphoinositide br akdown i PC12 
cells 
cpm in [3H]inositol °70 control 
phosphate per 
10000 cpm in lipids 
Normal media 
Control 550 _+ 86 100 
MTX (0.5 ng/ml) 2140 _+ 480 390 
+ nifedipine (10/~M) 1750 +_ 350 320 
Calcium-free medium 
Control 270 + 9 100 
MTX (0.5 ng/ml) 300 _+ 17 110 
Sodium-free medium 
Control 370 100 
MTX (0.5 ng/ml) 1030 280 
PC12 cells labeled with [3H]inositol were preincubated with 
media containing LiC1 for 20 min. Incubations were then 
carried out for 30 min. [3H]Inositol phosphates were xtracted 
and separated asindicated insection 2. Results are means of 3 
independent experiments (_+ SE) or from a single xperiment 
performed in triplicate 
4. DISCUSSION 
Application of MTX to PC12 cells at concentra- 
tions of 2-40 ng/ml causes the release of ATP co- 
stored with catecholamines in the secretory 
granules (fig.l). The kinetics of release are consis- 
tent with the release of ATP from the vesicular 
pool. These results are in agreement with previous 
work [1] in which MTX evoked the release of 
[3Hlnorepinephrine i  PC12 cells. The observed in- 
hibitory effect of the calcium channel blocker 
nifedipine (fig.2) is also consistent with results [1] 
showing inhibition by nifedipine of MTX-evoked 
release of norepinephrine in PCI2 cells. Further- 
more, stimulatory effects of MTX on release of 
neurotransmitters and hormones are also inhibited 
in other cell types by calcium channel blockers 
[6,10]. Thus, it appears that at concentrations 
>2 ng/ml, used in the present study and in other 
reports [1,5,6], MTX interacts directly with the L- 
subclass of calcium channels that are sensitive to 
dihydropyridines, and thereby triggers calcium- 
dependent release processes. 
MTX at  lower concentrations (0.5-1 ng/ml) 
markedly stimulates phosphoinositide breakdown 
in PC12 cells (fig.3). Stimulatory effects of MTX 
on phosphoinositide breakdown have been ob- 
served in aortic myocytes [11], NCB-20 cells [12] 
and synaptoneurosomes [13], Higher concentra- 
tions of MTX have less or  no effect on phospho- 
inositide breakdown in PC12 cells (fig.3). Similar 
dose-response r lationships pertained for MTX- 
elicited stimulation o f  phosphoinositide break- 
down in NCB-20 cells [12]. Stimulation of phos- 
phoinositide breakdctwn by MTX in PC12 cells is 
not sensitive to calcium channel blockers, in- 
cluding nifedipine, but it is eliminated in the 
absence of extracellular calcium (table 1). MTX 
had been previously shown to elicit calcium- 
dependent phosphoinositide breakdown, resistant 
to inhibition by calcium channel blockers in 
NCB-20 cells [12] and in aortic myocytes [11]. 
The concentration of MTX required to elicit 
release of ATP in PC12 cells is at least 4-fold 
greater than that required to stimulate 
phosphoinositide breakdown in the same cells (cf. 
figs 1,3), suggesting that two independent 
mechanisms are involved in these responses. In- 
deed, prior literature would also indicate that 
systems involved in phosphoinositide breakdown 
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[11,12] are much more sensitive to MTX than are 
systems involved in stimulation of calcium uptake, 
muscle contraction and neurotransmitter release 
[1,5,6]. However, the range of concentrations of 
MTX that have been reported to be required to 
elicit biological responses is quite broad. Thus, in 
PC12 cells MTX can evoke secretion at concentra- 
tions in the range 1-100 ng/ml [1]. In cultured 
neurons release is seen only at higher concentra- 
tions, ranging between 100 and 1000 ng/ml [5]. In 
NG108-15 cells MTX-induced calcium uptake is 
observed at concentrations in the range 
30-100 ng/ml [6], while in pancreatic islet cells 
MTX stimulates calcium uptake and evokes insulin 
release at relatively low concentrations of 
0.03-1 ng/ml [4]. The chemical structure of MTX 
is as yet unknown, and it is uncertain whether the 
purity and activity of preparations of MTX from 
different laboratories are identical. However, in 
the present study the same MTX preparation was 
used with the same cell type. Thus, the observatiofl 
that MTX elicited the two biological responses at 
markedly different ranges of concentration pro- 
vides strong evidence that MTX affects ATP 
release through a less sensitive pathway, involving 
activation of nifedipine-sensitive calcium channels, 
while affecting phosphoinositide breakdown 
through a more sensitive pathway, not involving 
calcium channels ensitive to nifedipine and other 
channel blockers. It is, however, possible that the 
primary event is stimulation of phosphoinositide 
breakdown and that at concentrations of 
> 2 ng/ml MTX, second messengers generated in- 
itially through phosphoinositide breakdown result 
in activation of L-type calcium channels, thereby 
triggering release of neurotransmitters. 
MTX stimulates phosphoinositide breakdown in 
a wide variety of cell types (unpublished). 
Although the molecular mechanism of stimulation 
of phosphoinositide breakdown by MTX remains 
to be determined, MTX may prove to be a general 
activator of phospholipase (s) C involved in 
phosphoinositide breakdown either directly or in 
some way by enhancing calcium input to the 
system. 
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